Xiong Serena, Ghebre Rahel, Kulasingam Shalini, Mason Susan M, Pratt Rebekah J, Lazovich DeAnn
Department of Surgery, Washington University in St. Louis School of Medicine, 600 S Taylor Avenue, St. Louis, MO 63110, United States.
Department of Obstetrics, Gynecology and Women's Health, University of Minnesota Medical School, 420 Delaware St SE, Minneapolis, MN 55455, United States.
Prev Med Rep. 2023 May 13;34:102243. doi: 10.1016/j.pmedr.2023.102243. eCollection 2023 Aug.
Pap tests are still underutilized by minority women due to limited awareness of cervical cancer screening (CCS), inadequate health care access, and cultural or religious beliefs. Human papillomavirus (HPV) self-sampling, a new CCS tool, has demonstrated potential to overcome some of these barriers. In 2021, women aged 30-65 years old were recruited across Minnesota to complete an online survey. The survey assessed five outcome measures related to HPV self-sampling: (1) awareness of test; (2) self-efficacy to conduct test; (3) location preference of test (clinic vs. home); 4) collector preference (self vs. clinician); and (5) preference of CCS strategy (HPV self-sampling vs. Pap test). Modified Poisson regressions tested associations between sociodemographic variables and outcomes. A total of 420 women completed the survey, of which 32.4% identified as Non-Hispanic white, 22.2% as Hispanic, 12.6% as Black/African-American, 28.3% as Asian, 1.9% as American Indian/Alaskan Native, and 1.4% as more than two races. Few women had heard of HPV self-sampling (6.5%), but a majority reported high self-efficacy to perform self-sampling (75.3%). Women also reported higher preferences for completing an HPV test in the clinic (52.2%) and for performing a self-collected HPV test themselves (58.7%), yet would choose a traditional Pap test over HPV self-sampling (56.0%). The low level of HPV self-sampling awareness, across all racial/ethnic groups, suggests a strong opportunity to promote widespread educational efforts around this new tool. Future HPV self-sampling research efforts should examine educational interventions targeted at healthcare providers to educate and encourage women on the importance of self-collection options.
由于对宫颈癌筛查（CCS）的认识有限、医疗保健服务获取不足以及文化或宗教信仰等原因，巴氏试验在少数族裔女性中仍未得到充分利用。人乳头瘤病毒（HPV）自我采样作为一种新的宫颈癌筛查工具，已显示出克服其中一些障碍的潜力。2021年，明尼苏达州各地招募了30至65岁的女性来完成一项在线调查。该调查评估了与HPV自我采样相关的五项结果指标：（1）对检测的认识；（2）进行检测的自我效能感；（3）检测地点偏好（诊所与家中）；（4）采集者偏好（自我采集与临床医生采集）；以及（5）宫颈癌筛查策略偏好（HPV自我采样与巴氏试验）。修正泊松回归分析了社会人口统计学变量与结果之间的关联。共有420名女性完成了调查，其中32.4%为非西班牙裔白人，22.2%为西班牙裔，12.6%为黑人/非裔美国人，28.3%为亚洲人，1.9%为美洲印第安人/阿拉斯加原住民，1.4%为两个以上种族。很少有女性听说过HPV自我采样（6.5%），但大多数女性报告称进行自我采样的自我效能感较高（75.3%）。女性还表示更倾向于在诊所完成HPV检测（52.2%）以及自己进行自我采集的HPV检测（58.7%），然而与HPV自我采样相比，她们会选择传统巴氏试验（56.0%）。所有种族/族裔群体中HPV自我采样的低认知水平表明，围绕这一新工具开展广泛教育工作的机会很大。未来HPV自我采样的研究工作应考察针对医疗保健提供者的教育干预措施，以教育和鼓励女性认识自我采集选项的重要性。
